Abstract:Background: Pulmonary sarcomatoid carcinoma (PSC) is a rare subtype of non-small cell lung cancer (NSCLC), which is featured by low incidence, high malignancy rate, robust aggressive behavior and inferior prognosis. To date, there is no standardized treatment. The aim of this study is to better understand and accumulate more clinical experience of the disease by summarizing the clinicopathological features, diagnosis methods, therapeutic regimen and prognostic factors of PSC. Methods: A total of 39 patients with PSC who diagnosed and received treatment in Beijing Chest Hospital from December 2013 to December 2023 were retrospectively recruited, and information including demographic characteristics, clinicopathological features, tumor-node-metastasis (TNM) stage, diagnosis method and therapeutic regimen were carefully collected. Meanwhile, follow-up was conducted. Kaplan-Meier method was used to analyze the prognostic factors of the disease. Results: The PSC patients in this study ranged in age from 45 to 76 years old, including 35 males and 4 females. There were no specific clinical manifestations of PSC at initial diagnosis. Among the 39 patients, 20 underwent surgical resection and 19 received palliative chemoradiation or symptomatic supportive treatment. The 1-year and 5-year survival rates were 61.90% and 35.20% respectively. Univariate analysis indicated that family history of carcinoma, primary tumor site, TNM stage, lymph node metastasis, distant metastasis, whether or not received surgical resection, surgical method, treatment regimens, tumor tissue programmed cell death ligand 1 (PD-L1) expression ≥1% and mesenchymal-epithelial transition factor (MET) pathway abnormalities were correlated with the overall survival (OS) of patients (P<0.05). In the subsequent multivariate analysis, lymph node metastasis emerged as the only independent prognosticator in predicting inferior OS (P=0.037). Conclusions: PSC is rarely seen in clinical practice and commonly occurs in elder men with smoking history. Tumor tissue PD-L1 expression ≥1% and MET abnormalities may predict inferior prognosis of PSC and lymph node metastasis was determined as the independent prognosticator of PSC. Surgical resection along with adjuvant medical treatment is the cornerstone for early and locally advanced patients, and the clinical utility of molecular targeting therapy and immunotherapy in PSC needs to be further investigated.

Sarcomatoid renal pelvis carcinoma: Experience of treatment at a single-institution

Sarcomatoid carcinoma of the renal pelvis: Experience of multiple cases over a ten-year period.

Cystic renal cell carcinoma: a report of 67 cases including 4 cases with concurrent renal cell carcinoma

Sarcomatoid Carcinoma of the Renal Pelvis in Duplex Kidney.

Prognostic Value of Site-Specific Metastases and Therapeutic Roles of Surgery and Chemotherapy for Patients With Metastatic Renal Pelvis Cancer: A SEER Based Study

Treatment algorithm and surgical outcome for primary and recurrent retroperitoneal sarcomas: A long-term single-center experience of 242 cases

Comprehensive treatment of primary pelvic synovial sarcoma: A 28-month follow-up case report and review of the literature

Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience

[Prostate Sarcoma: A Retrospective Analysis of 26 Cases].

[Clinicopathological Characteristics and Prognosis Analysis of 39 Patients with Pulmonary Sarcomatoid Carcinoma]

Clinicopathologic characteristics, therapy and outcomes of patients with primary ureteral small cell carcinoma: a case series and systematic review of the literature.

Clinicopathological Characteristics and Treatment Outcomes of Chinese Patients with Genitourinary Embryonal Rhabdomyosarcoma

[Diagnosis and treatment of sarcomatoid renal cell carcinoma]

Toripalimab in combination with chemotherapy effectively suppresses local recurrence and metastatic sarcomatoid renal cell carcinoma: A case report

Clinicopathological characteristics and prognosis of uterine sarcoma: a 10-year retrospective single-center study in China

Sarcomatoid carcinoma of the pancreas (Review)

Retrospective Analysis of Outcomes in Patients with Clear Cell Sarcoma of the Kidney: A Tertiary Single-Institution Experience.

Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder

Case report: Sarcomatoid renal cell carcinoma masquerading as hydronephrosis

Pulmonary Sarcomatoid Carcinoma: Experience From SEER Database and Shanghai Pulmonary Hospital

Undifferentiated Pleomorphic Sarcoma: Long-Term Follow-Up from a Large Institution